You are here: Home / Our people / Professor Philip Hazell 

Professor Philip Hazell

Professor
Psychiatry, Concord Clinical School

Telephone +61 2 9736 2288
Fax +61 2 4924 6056

Curriculum vitae Curriculum vitae

Map

Biographical details

Professor Philip Hazell is Conjoint Professor of Child and Adolescent Psychiatry with the Sydney Medical School. He is in addition Director of Child and Adolescent Mental Health Services for the Sydney Local HealthDistrict and Director of the Rivendell Child, Adolescent and Family Mental Health Service.

Philip completed his undergraduate medical training with University of Otago in 1980 and trained in general psychiatry and child psychiatry in Adelaide, South Australia from 1983 to 1989. From 1989 to 1998 Philip was Lecturer/Senior Lecturer in Psychiatry with the University of Newcastle, and then until 2006 he was Clinical Director of the Child and Youth Mental Health Service, Hunter New England Mental Health Service.

Back to Top

Research interests

Philip was awarded a PhD in 1997 for a thesis concerning automatic and effortful information processing in ADHD. His other research output spans youth suicide and deliberate self-harm, mood disorders, autism, children in out-of-home care, systematic review of treatment effectiveness, psychological sequelae of disaster, and the evaluation of medical education. He was in 2004 honoured by the American Academy of Child and Adolescent Psychiatry with the Elaine Schlosser Lewis Award for Research in Attention Deficit Disorder. He is currently a co-investigator on funded longitudinal studies of children with Attention Deficit Hyperactivity Disorder and of determinants of health and wellbeing in adolescents in rural New South Wales. He is also a co-investigator on a funded clinical trial of fluoxetine for autism.

Back to Top

Selected grants

2014

  • Trajectories in brain structure and function for children with and without ADHD: Associations with academic, cognitive, social, and mental health outcomes; Silk T, Anderson V, Sciberras E, Nicholson J, Efron D, Hazell P; National Health and Medical Research Council (NHMRC)/Project Grants.

2011

  • Adolescent Rural Cohort Study Hormones, Health, Education, Environments and Relationships; Steinbeck K, Hawke C, Hazell P, Skinner R, Ivers R, Booy R, Cumming R, Fulcher G; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • Sleep, puberty and depression; Hazell P, Chow C, Steinbeck K, Hawke C; Australian Rotary Health Research Fund/Mental Health Research Grants.

2009

  • Juvenile Bipolar Disorder: Evaluation of Symptom Profiles, Treatment Outcomes, and Predictors of Treatment Effectiveness for Clients from a Community Mental Health Clinic; Hazell P, Hirneth S, Hirneth S, Hanstock T; Australian Rotary Health Research Fund/Research Support.
Back to Top

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Hazell, P. (2013). Suicide and Self-Harm. In Kate Steinbeck, Michael Kohn (Eds.), A Clinical Handbook in Adolescent Medicine: A Guide for Health Professionals Who Work with Adolescents and Young Adults, (pp. 373-382). Singapore: World Scientific Publishing.
  • Rey, J., Hazell, P. (2009). Depression in Children and Adolescents. In Joseph Rey, Boris Birmaher (Eds.), Treating Child and Adolescent Depression, (pp. 3-16). United States: Lippincott Williams & Wilkins.
  • Rey, J., Hazell, P., Patton, G., Tonge, B. (2001). Child and Adolescent Psychiatry. In S Bloch and BS Singh (Eds.), Foundations of Clinical Psychiatry (2nd edition), (pp. 359-392). Australia: Melbourne University Press.

Journals

  • Mouti, A., Reddihough, D., Marraffa, C., Hazell, P., Wray, J., Lee, K., Kohn, M. (2014). Fluoxetine for Autistic Behaviors (FAB trial): Study protocol for a randomized controlled trial in children and adolescents with autism. Trials, 15(1), 230. [More Information]
  • Efron, D., Sciberras, E., Anderson, V., Hazell, P., Ukoumunne, O., Jongeling, B., Schilpzand, E., Bisset, M., Nicholson, J. (2014). Functional Status in Children With ADHD at Age 6-8: A Controlled Community Study. Pediatrics, 134(4), e992-e1000. [More Information]
  • Balzer, B., Kelly, P., Hazell, P., Paxton, K., Hawke, C., Steinbeck, K. (2014). Text messaging is a useful reminder tool. ARCHIVES OF DISEASE IN CHILDHOOD, 99(7), 666-667. [More Information]
  • Chudleigh, C., Kozlowska, K., Kothur, K., Davies, F., Baxter, H., Landini, A., Hazell, P., Baslet, G. (2013). Managing Non-epileptic Seizures and Psychogenic Dystonia in an Adolescent Girl with Preterm Brain Injury. Harvard Review of Psychiatry, 21(3), 163-174. [More Information]
  • Honey, A., Fraser, V., Llewellyn, G., Hazell, P., Clarke, S. (2013). Parental influence on the mental health-related behaviour of young people with mental illness: Young people's perceptions. Australian e-Journal for the Advancement of Mental Health, 12(1), 63-74.
  • Williams, K., Brignell, A., Randall, M., Silove, N., Hazell, P. (2013). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD) (Review). Cochrane Database of Systematic Reviews, 8, 1-49. [More Information]
  • Sciberras, E., Efron, D., Schilpzand, E., Anderson, V., Jongeling, B., Hazell, P., Ukoumunne, O., Nicholson, J. (2013). The Children's Attention Project: A community-based longitudinal study of children with ADHD and non-ADHD controls. BMC Psychiatry, 13, 1-11. [More Information]
  • Hazell, P., Mirzaie, M. (2013). Tricyclic drugs for depression in children and adolescents. Cochrane Database of Systematic Reviews, 6, 1-48. [More Information]
  • Hazell, P., Jairam, R. (2012). Acute treatment of mania in children and adolescents. Current Opinion in Psychiatry, 25(4), 264-270. [More Information]
  • Swannell, S., Martin, G., Page, A., Hasking, P., Hazell, P., Taylor, A., Protani, M. (2012). Child maltreatment, subsequent non-suicidal self-injury and the mediating roles of dissociation, alexithymia and self-blame. Child Abuse and Neglect, 36(7-8), 572-584. [More Information]
  • Eapen, V., Faure-Brac, G., Ward, P., Hazell, P., Barton, G., Asghari-Fard, M., Dullur, P. (2012). Evaluation of weight gain and metabolic parameters among adolescent psychiatric inpatients: Role of health promotion and life style intervention programs. Journal of Metabolic Syndrome, 1(3), Article no. 1000109. [More Information]
  • van Wyk, G., Hazell, P., Kohn, M., Granger, R., Walton, R. (2012). How Oppositionality, Inattention, and Hyperactivity Affect Response to Atomoxetine Versus Methylphenidate: A Pooled Meta-Analysis. Journal of Attention Disorders, 16(4), 314-324. [More Information]
  • Hazell, P., Williams, R. (2012). Sport is good, war is bad: discuss. Current Opinion in Psychiatry, 25(4), 261-263. [More Information]
  • Steinbeck, K., Hazell, P., Cumming, R., Skinner, R., Ivers, R., Booy, R., Fulcher, G., Handelsman, D., Martin, A., Morgan, G., Starling, J., Bauman, A., Rawsthorne, M., Chow, C., Lam, M., Kelly, P., Paxton, K., Hawke, C., et al (2012). The study design and methodology for the ARCHER Study - Adolescent Rural Cohort Study of Hormones, Health, Education, Environments and Relationships. BMC Pediatrics, 12, 1-10. [More Information]
  • Hurwitz, R., Blackmore, R., Hazell, P., Williams, K., Woolfenden, S. (2012). Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents (Review). Cochrane Database of Systematic Reviews, 3, 1-31. [More Information]
  • Williams, R., Hazell, P. (2011). Austerity, poverty, resilience, and the future of mental health services for children and adolescents. Current Opinion in Psychiatry, 24(4), 263-266. [More Information]
  • Hazell, P., Kohn, M., Dickson, R., Walton, R., Granger, R., van Wyk, G. (2011). Core ADHD Symptom Improvement With Atomoxetine Versus Methylphenidate: A Direct Comparison Meta-Analysis. Journal of Attention Disorders, 15(8), 674-683. [More Information]
  • Hazell, P. (2011). Depression in Children and Adolescents. Clinical Evidence, 2011, 1-69. [More Information]
  • Taylor, A., Martin, G., Grande, E., Swannell, S., Fullerton, S., Hazell, P., Harrison, J. (2011). Methodological issues associated with collecting sensitive information over the telephone-experience from an Australian non-suicidal self-injury (NSSI) prevalence study. BMC Medical Research Methodology, 11, Article No 20 - 1-Article No 20 - 7. [More Information]
  • Hazell, P. (2011). The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder. Current Opinion in Psychiatry, 24(4), 286-290. [More Information]
  • Efron, D., Hazell, P., Anderson, V. (2011). Update on attention deficit hyperactivity disorder. Journal of Paediatrics and Child Health, 47(10), 682-689. [More Information]
  • Hazell, P. (2010). Pharmacological managment of attention-deficit/hyperactivity disorder in adolescents: an update. SII Csalud, 1.
  • Hazell, P. (2010). Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder. Australasian Psychiatry, 18(6), 556-559. [More Information]
  • Williams, K., Wheeler, D., Silove, N., Hazell, P. (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews, DOI: 10.1002/14651858.CD004677.pub2(8), 1-34. [More Information]
  • Williams, K., Hazell, P. (2010). Selective serotonin reuptake inhibitors for autism spectrum disorders. Journal of Evidence-Based Medicine, 3(4), 231. [More Information]
  • Martin, G., Swannell, S., Hazell, P., Harrison, J., Taylor, A. (2010). Self-injury in Australia: a community survey. Medical Journal of Australia, 193(9), 506-510. [More Information]
  • Hazell, P., Williams, R. (2010). Should clinicians engaged in delivering evidence-based child and adolescent mental healthcare be excited about findings from empirical research? Current Opinion in Psychiatry, 23(4), 299-303. [More Information]
  • Hazell, P. (2009). 8-year follow-up of the MTA sample. Journal of the American Academy of Child and Adolescent Psychiatry. [More Information]
  • Hazell, P. (2009). Depression in children and adolescents. Clinical Evidence, 1(1008), 1-31. [More Information]
  • Hazell, P., Martin, G., McGill, K., Kay, T., Wood, A., Tainor, G., Harrington, R. (2009). Group therapy for repeated deliberate self-harm in adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48(6), 662-670. [More Information]
  • Williams, R., Hazell, P. (2009). Implementing guidance and guidelines for developing and delivering equitable child and adolescent mental health services. Current Opinion in Psychiatry, 22(4), 339-344. [More Information]
  • Clayton, E., Hanstock, T., Hirneth, S., Kable, C., Garg, M., Hazell, P. (2009). Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. European Journal of Clinical Nutrition, 63(8), 1037-40. [More Information]
  • Hazell, P., Becker, K., Nikkanen, E., Trzepacz, P., Tanaka, Y., Tabas, L., D'Souza, D., Witcher, J., Long, A., Ponsler, G., et al (2009). Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. ADHD - Attention Deficit and Hyperactivity Disorders, 1(2), 201-210. [More Information]
  • Bangs, M., Hazell, P., Danckaerts, M., Hoare, P., Coghill, D., Wehmeier, P., Williams, D., Moore, R., Levine, L. (2008). Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics (English Edition), 121(2), e314-320. [More Information]
  • Hazell, P., Williams, R. (2008). Editorial review: shifting views on juvenile bipolar disorder and pervasive developmental disorder. Current Opinion in Psychiatry, 21(4), 328-331. [More Information]
  • Clayton, E., Hanstock, T., Hirneth, S., Kable, C., Garg, M., Hazell, P. (2008). Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder. Lipids, 43(33), 1031-1038. [More Information]
  • Jairam, R., Cahill, C., Hanstock, T., Hazell, P., Walter, G., Malhi, G. (2008). The changing face of bipolar disorder: adolescence to adulthood. Minerva Pediatrica, 60(1), 59-68. [More Information]
  • Cahill, C., Hanstock, T., Jairam, R., Hazell, P., Walter, G., Malhi, G. (2007). Comparison of diagnostic guidelines for juvenile bipolar disorder. Australian and New Zealand Journal of Psychiatry, 41(6), 479-484. [More Information]
  • Hazell, P. (2007). Depression in adolescents. BMJ (online), 335(7611), 106-107. [More Information]
  • Hazell, P. (2007). Does the treatment of mental disorders in childhood lead to a healthier adulthood? Current Opinion in Psychiatry, 20(4), 315-318. [More Information]
  • Hazell, P. (2007). Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder. Journal of Paediatrics and Child Health, 43(1-Feb), 19-24. [More Information]
  • Clayton, E., Hanstock, T., Garg, M., Hazell, P. (2007). Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents. Acta Neuropsychiatrica, 19(2), 92-103.
  • Hazell, P. (2007). Pharmacological management of attention-deficit hyperactivity disorder in adolescents: special considerations. CNS Drugs, 21(1), 37-46. [More Information]
  • Tarren-Sweeney, M., Hazell, P. (2006). Mental health of children in foster and kinship care in New South Wales, Australia. Journal of Paediatrics and Child Health, 42(3), 89-97. [More Information]
  • Chan, R., Rey, J., Hazell, P. (2002). Clinical practice guidelines for depression in young people: are the treatment recommendations outdated? Medical Journal of Australia, 177(8), 440-443.
  • Sawyer, M., Whaites, L., Rey, J., Hazell, P., Graetz, B., Baghurst, P. (2002). Health-related quality of life of children and adolescents with mental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 41(5), 530-537.

Conferences

  • Maddox, R., Chow, C., Hawke, C., Paxton, K., Steinbeck, K., Hazell, P. (2011). A longitudinal study of sleep patterns in mid-adolescence. The 8th Australian & New Zealand Adolescent Health Conference: Youth Health 2011: It's Totally Important!, Not-Known.

2014

  • Mouti, A., Reddihough, D., Marraffa, C., Hazell, P., Wray, J., Lee, K., Kohn, M. (2014). Fluoxetine for Autistic Behaviors (FAB trial): Study protocol for a randomized controlled trial in children and adolescents with autism. Trials, 15(1), 230. [More Information]
  • Efron, D., Sciberras, E., Anderson, V., Hazell, P., Ukoumunne, O., Jongeling, B., Schilpzand, E., Bisset, M., Nicholson, J. (2014). Functional Status in Children With ADHD at Age 6-8: A Controlled Community Study. Pediatrics, 134(4), e992-e1000. [More Information]
  • Balzer, B., Kelly, P., Hazell, P., Paxton, K., Hawke, C., Steinbeck, K. (2014). Text messaging is a useful reminder tool. ARCHIVES OF DISEASE IN CHILDHOOD, 99(7), 666-667. [More Information]

2013

  • Chudleigh, C., Kozlowska, K., Kothur, K., Davies, F., Baxter, H., Landini, A., Hazell, P., Baslet, G. (2013). Managing Non-epileptic Seizures and Psychogenic Dystonia in an Adolescent Girl with Preterm Brain Injury. Harvard Review of Psychiatry, 21(3), 163-174. [More Information]
  • Honey, A., Fraser, V., Llewellyn, G., Hazell, P., Clarke, S. (2013). Parental influence on the mental health-related behaviour of young people with mental illness: Young people's perceptions. Australian e-Journal for the Advancement of Mental Health, 12(1), 63-74.
  • Williams, K., Brignell, A., Randall, M., Silove, N., Hazell, P. (2013). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD) (Review). Cochrane Database of Systematic Reviews, 8, 1-49. [More Information]
  • Hazell, P. (2013). Suicide and Self-Harm. In Kate Steinbeck, Michael Kohn (Eds.), A Clinical Handbook in Adolescent Medicine: A Guide for Health Professionals Who Work with Adolescents and Young Adults, (pp. 373-382). Singapore: World Scientific Publishing.
  • Sciberras, E., Efron, D., Schilpzand, E., Anderson, V., Jongeling, B., Hazell, P., Ukoumunne, O., Nicholson, J. (2013). The Children's Attention Project: A community-based longitudinal study of children with ADHD and non-ADHD controls. BMC Psychiatry, 13, 1-11. [More Information]
  • Hazell, P., Mirzaie, M. (2013). Tricyclic drugs for depression in children and adolescents. Cochrane Database of Systematic Reviews, 6, 1-48. [More Information]

2012

  • Hazell, P., Jairam, R. (2012). Acute treatment of mania in children and adolescents. Current Opinion in Psychiatry, 25(4), 264-270. [More Information]
  • Swannell, S., Martin, G., Page, A., Hasking, P., Hazell, P., Taylor, A., Protani, M. (2012). Child maltreatment, subsequent non-suicidal self-injury and the mediating roles of dissociation, alexithymia and self-blame. Child Abuse and Neglect, 36(7-8), 572-584. [More Information]
  • Eapen, V., Faure-Brac, G., Ward, P., Hazell, P., Barton, G., Asghari-Fard, M., Dullur, P. (2012). Evaluation of weight gain and metabolic parameters among adolescent psychiatric inpatients: Role of health promotion and life style intervention programs. Journal of Metabolic Syndrome, 1(3), Article no. 1000109. [More Information]
  • van Wyk, G., Hazell, P., Kohn, M., Granger, R., Walton, R. (2012). How Oppositionality, Inattention, and Hyperactivity Affect Response to Atomoxetine Versus Methylphenidate: A Pooled Meta-Analysis. Journal of Attention Disorders, 16(4), 314-324. [More Information]
  • Hazell, P., Williams, R. (2012). Sport is good, war is bad: discuss. Current Opinion in Psychiatry, 25(4), 261-263. [More Information]
  • Steinbeck, K., Hazell, P., Cumming, R., Skinner, R., Ivers, R., Booy, R., Fulcher, G., Handelsman, D., Martin, A., Morgan, G., Starling, J., Bauman, A., Rawsthorne, M., Chow, C., Lam, M., Kelly, P., Paxton, K., Hawke, C., et al (2012). The study design and methodology for the ARCHER Study - Adolescent Rural Cohort Study of Hormones, Health, Education, Environments and Relationships. BMC Pediatrics, 12, 1-10. [More Information]
  • Hurwitz, R., Blackmore, R., Hazell, P., Williams, K., Woolfenden, S. (2012). Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents (Review). Cochrane Database of Systematic Reviews, 3, 1-31. [More Information]

2011

  • Maddox, R., Chow, C., Hawke, C., Paxton, K., Steinbeck, K., Hazell, P. (2011). A longitudinal study of sleep patterns in mid-adolescence. The 8th Australian & New Zealand Adolescent Health Conference: Youth Health 2011: It's Totally Important!, Not-Known.
  • Williams, R., Hazell, P. (2011). Austerity, poverty, resilience, and the future of mental health services for children and adolescents. Current Opinion in Psychiatry, 24(4), 263-266. [More Information]
  • Hazell, P., Kohn, M., Dickson, R., Walton, R., Granger, R., van Wyk, G. (2011). Core ADHD Symptom Improvement With Atomoxetine Versus Methylphenidate: A Direct Comparison Meta-Analysis. Journal of Attention Disorders, 15(8), 674-683. [More Information]
  • Hazell, P. (2011). Depression in Children and Adolescents. Clinical Evidence, 2011, 1-69. [More Information]
  • Taylor, A., Martin, G., Grande, E., Swannell, S., Fullerton, S., Hazell, P., Harrison, J. (2011). Methodological issues associated with collecting sensitive information over the telephone-experience from an Australian non-suicidal self-injury (NSSI) prevalence study. BMC Medical Research Methodology, 11, Article No 20 - 1-Article No 20 - 7. [More Information]
  • Hazell, P. (2011). The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder. Current Opinion in Psychiatry, 24(4), 286-290. [More Information]
  • Efron, D., Hazell, P., Anderson, V. (2011). Update on attention deficit hyperactivity disorder. Journal of Paediatrics and Child Health, 47(10), 682-689. [More Information]

2010

  • Hazell, P. (2010). Pharmacological managment of attention-deficit/hyperactivity disorder in adolescents: an update. SII Csalud, 1.
  • Hazell, P. (2010). Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder. Australasian Psychiatry, 18(6), 556-559. [More Information]
  • Williams, K., Wheeler, D., Silove, N., Hazell, P. (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews, DOI: 10.1002/14651858.CD004677.pub2(8), 1-34. [More Information]
  • Williams, K., Hazell, P. (2010). Selective serotonin reuptake inhibitors for autism spectrum disorders. Journal of Evidence-Based Medicine, 3(4), 231. [More Information]
  • Martin, G., Swannell, S., Hazell, P., Harrison, J., Taylor, A. (2010). Self-injury in Australia: a community survey. Medical Journal of Australia, 193(9), 506-510. [More Information]
  • Hazell, P., Williams, R. (2010). Should clinicians engaged in delivering evidence-based child and adolescent mental healthcare be excited about findings from empirical research? Current Opinion in Psychiatry, 23(4), 299-303. [More Information]

2009

  • Hazell, P. (2009). 8-year follow-up of the MTA sample. Journal of the American Academy of Child and Adolescent Psychiatry. [More Information]
  • Hazell, P. (2009). Depression in children and adolescents. Clinical Evidence, 1(1008), 1-31. [More Information]
  • Rey, J., Hazell, P. (2009). Depression in Children and Adolescents. In Joseph Rey, Boris Birmaher (Eds.), Treating Child and Adolescent Depression, (pp. 3-16). United States: Lippincott Williams & Wilkins.
  • Hazell, P., Martin, G., McGill, K., Kay, T., Wood, A., Tainor, G., Harrington, R. (2009). Group therapy for repeated deliberate self-harm in adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48(6), 662-670. [More Information]
  • Williams, R., Hazell, P. (2009). Implementing guidance and guidelines for developing and delivering equitable child and adolescent mental health services. Current Opinion in Psychiatry, 22(4), 339-344. [More Information]
  • Clayton, E., Hanstock, T., Hirneth, S., Kable, C., Garg, M., Hazell, P. (2009). Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. European Journal of Clinical Nutrition, 63(8), 1037-40. [More Information]
  • Hazell, P., Becker, K., Nikkanen, E., Trzepacz, P., Tanaka, Y., Tabas, L., D'Souza, D., Witcher, J., Long, A., Ponsler, G., et al (2009). Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. ADHD - Attention Deficit and Hyperactivity Disorders, 1(2), 201-210. [More Information]

2008

  • Bangs, M., Hazell, P., Danckaerts, M., Hoare, P., Coghill, D., Wehmeier, P., Williams, D., Moore, R., Levine, L. (2008). Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics (English Edition), 121(2), e314-320. [More Information]
  • Hazell, P., Williams, R. (2008). Editorial review: shifting views on juvenile bipolar disorder and pervasive developmental disorder. Current Opinion in Psychiatry, 21(4), 328-331. [More Information]
  • Clayton, E., Hanstock, T., Hirneth, S., Kable, C., Garg, M., Hazell, P. (2008). Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder. Lipids, 43(33), 1031-1038. [More Information]
  • Jairam, R., Cahill, C., Hanstock, T., Hazell, P., Walter, G., Malhi, G. (2008). The changing face of bipolar disorder: adolescence to adulthood. Minerva Pediatrica, 60(1), 59-68. [More Information]

2007

  • Cahill, C., Hanstock, T., Jairam, R., Hazell, P., Walter, G., Malhi, G. (2007). Comparison of diagnostic guidelines for juvenile bipolar disorder. Australian and New Zealand Journal of Psychiatry, 41(6), 479-484. [More Information]
  • Hazell, P. (2007). Depression in adolescents. BMJ (online), 335(7611), 106-107. [More Information]
  • Hazell, P. (2007). Does the treatment of mental disorders in childhood lead to a healthier adulthood? Current Opinion in Psychiatry, 20(4), 315-318. [More Information]
  • Hazell, P. (2007). Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder. Journal of Paediatrics and Child Health, 43(1-Feb), 19-24. [More Information]
  • Clayton, E., Hanstock, T., Garg, M., Hazell, P. (2007). Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents. Acta Neuropsychiatrica, 19(2), 92-103.
  • Hazell, P. (2007). Pharmacological management of attention-deficit hyperactivity disorder in adolescents: special considerations. CNS Drugs, 21(1), 37-46. [More Information]

2006

  • Tarren-Sweeney, M., Hazell, P. (2006). Mental health of children in foster and kinship care in New South Wales, Australia. Journal of Paediatrics and Child Health, 42(3), 89-97. [More Information]

2002

  • Chan, R., Rey, J., Hazell, P. (2002). Clinical practice guidelines for depression in young people: are the treatment recommendations outdated? Medical Journal of Australia, 177(8), 440-443.
  • Sawyer, M., Whaites, L., Rey, J., Hazell, P., Graetz, B., Baghurst, P. (2002). Health-related quality of life of children and adolescents with mental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 41(5), 530-537.

2001

  • Rey, J., Hazell, P., Patton, G., Tonge, B. (2001). Child and Adolescent Psychiatry. In S Bloch and BS Singh (Eds.), Foundations of Clinical Psychiatry (2nd edition), (pp. 359-392). Australia: Melbourne University Press.
Back to Top

To update your profile click here. For support on your academic profile contact .